Following the roll-out of the Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, and Janssen Ad26.COV2.S coronavirus disease 2019 (COVID-19) injections in the United States, millions of individuals have reported adverse events (AEs) using the vaccine adverse events reports system (VAERS).

The objective of this video is to describe the myocarditis data in VAERS and the COVID-19 vaccines as potential determinants of myocarditis.